Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer

BACKGROUND: Inflammatory myositis, such as dermatomyositis, is sometimes complicated by cancer and is recognized as cancer-associated myositis. Although some autoimmune antibodies are considered to be involved in the development of myositis in cancer patients, the precise mechanism has not been clar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Yuki, Tanino, Yoshinori, Nikaido, Takefumi, Togawa, Ryuichi, Kawamata, Takaya, Watanabe, Natsumi, Sato, Riko, Yamada, Ryuki, Onuma, Takumi, Tomita, Hikaru, Saito, Mikako, Rikimaru, Mami, Morimoto, Julia, Suzuki, Yasuhito, Minemura, Hiroyuki, Saito, Junpei, Kanazawa, Kenya, Yamada, Syoki, Hashimoto, Yuko, Shibata, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097056/
https://www.ncbi.nlm.nih.gov/pubmed/35549684
http://dx.doi.org/10.1186/s12890-022-01974-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097056/
https://www.ncbi.nlm.nih.gov/pubmed/35549684
http://dx.doi.org/10.1186/s12890-022-01974-4

Ejemplares similares